New award for venlafaxine HCL IR tablets with gsms, INC. Period of performance is 8/28/2021 - 8/27/2022 with four one-year options.

Ended Indefinite Delivery Contract Awarded Last action

Contract number
36E79721D0032
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 100% complete
IDV ceiling
$3,487,161.15
Award type
Single award
Who can order
Only the awarding agency
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

This indefinite delivery contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Golden State Medical Supply, Inc. (GSMS), a for-profit pharmaceutical manufacturer and distributor, to provide an uninterrupted supply of Venlafaxine HCL tablets. The contract has a base period of one year from August 28, 2021 to August 27, 2022, with four one-year option periods, for a total ceiling value of $3,487,161.15.

The contract items will be distributed through the VA's and Department of Defense's (DoD) respective Pharmaceutical Prime Vendor Programs, ensuring reliable pharmaceutical procurement across multiple government agencies including the VA, DoD, Bureau of Prisons, and Indian Health Service. The contract was not set aside for any specific business categories. The solicitation estimated annual requirements for various dosage strengths of Venlafaxine HCL tablets, ranging from 5,852 bottles of the 25mg tablets to 74,484 bottles of the 75mg tablets.

Transactions

Action Obligated Date
Exercise an Option P00006 · Exercising option year 4 for 6 months with gsms for venlafaxine HCL tablets. $0
Exercise an Option P00005 · Exercising option year 3 with gsms for venlafaxine HCL tablets. Period of performance is 8/28/2024 - 8/27/2025. $0
Supplemental Agreement for work within scope P00004 · CRF and sales reporting update $0
Exercise an Option P00003 · Exercise option year 2 for venlafaxine HCL tablets with golden state medical supply, INC. With no price changes. The period of performance is 8/28/23 - 8/27/24. $0
Other Administrative Action P00002 · Administrative modification to add drug supply chain security act language to contract. $0
Exercise an Option P00001 · Exercise option year 1, contract 36E79721D0032 for venlafaxine HCL IR tablets with gsms, INC. Period of performance is 08/28/2022 - 08/27/2023 with three… $0
Original award $0

Quick answers

Who was awarded contract 36E79721D0032?

36E79721D0032 was awarded to Golden State Medical Supply, Inc. by National Acquisition Center (Headquarters) on August 28, 2021.

How much is contract 36E79721D0032 worth?

36E79721D0032's own ceiling is $3,487,161.

Who can order from contract 36E79721D0032?

36E79721D0032 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract 36E79721D0032 competed?

The extent of competition for 36E79721D0032 was full and open competition. The government received 2 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV